MarketPeel
Insider Trading Intelligence
Pricing
…
AS

Anish Suri

CUE
PRESIDENT AND CSO · CUE BIOPHARMA, INC. · CIK 0001739130
FILING MIX · LIFETIME50%/50%
BUYS
21
SELLS
21
TOTAL VALUE
$1.65M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
150,000
AVG SELL PX
$14.74
TRADE KIND
SHOWING 42 / 42
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Anish Suri, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+28.57%-1.61%+0.74%-2.35%+0.89%—
14d7+42.86%-5.48%+1.11%-6.59%-7.00%—
30d7+85.71%-22.23%+2.80%-25.03%-23.31%—
60d7+85.71%-25.28%+1.26%-26.54%-23.59%—
90d7+85.71%-40.19%+0.83%-41.02%-43.93%—
180d7+85.71%-46.69%+4.54%-51.23%-45.48%—
1y7+85.71%-64.75%+13.40%-78.15%-81.08%—
2y7+100.00%+38.47%+19.13%+19.34%-85.87%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CUE · 150,000 shares · as of Jun 5, 2024
075,000150,000225,000300,0002021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
FLOW · 21 buys / 21 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Jun 5, 2024Jun 7, 2024 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
300,000——300,000Mar 6, 2024Mar 8, 2024 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
PRESIDENT AND CSO
4,000$2.76$11.0K135,638Aug 25, 2023Aug 29, 2023 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
124,125——124,125Jul 21, 2023Jul 25, 2023 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
125,500——125,500Feb 16, 2023Feb 21, 2023 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
PRESIDENT AND CSO
16,668——0Mar 31, 2022Apr 4, 2022 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
PRESIDENT AND CSO
16,668——110,706Mar 31, 2022Apr 4, 2022 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
PRESIDENT AND CSO
7,068$4.88$34.5K103,638Mar 31, 2022Apr 4, 2022 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
21,333——21,333Mar 25, 2022Mar 29, 2022 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
82,000——82,000Feb 9, 2022Mar 29, 2022 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
8,000$18.05$144.4K94,038Nov 15, 2021Nov 17, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
8,000——10,000Nov 15, 2021Nov 17, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
8,000$8.26$66.1K102,038Nov 15, 2021Nov 17, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
20,000——105,000Nov 11, 2021Nov 15, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
20,000$6.42$128.4K114,038Nov 11, 2021Nov 15, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
20,000$15.07$301.4K94,038Nov 11, 2021Nov 15, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
PRESIDENT AND CSO
14,134$12.97$183.3K94,038Oct 6, 2021Oct 8, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
PRESIDENT AND CSO
33,334——108,172Oct 3, 2021Oct 8, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
PRESIDENT AND CSO
33,334——0Oct 3, 2021Oct 8, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
PRESIDENT AND CSO
20,000$15.23$304.6K74,838Sep 23, 2021Sep 27, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
PRESIDENT AND CSO
20,000——125,000Sep 23, 2021Sep 27, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
PRESIDENT AND CSO
20,000$6.42$128.4K94,838Sep 23, 2021Sep 27, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
75,000——75,000Feb 10, 2021Feb 12, 2021 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
9,800$16.30$159.7K58,091Oct 5, 2020Oct 6, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
33,333——67,891Oct 3, 2020Oct 6, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
33,333——33,334Oct 3, 2020Oct 6, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
800$20.01$16.0K34,558Aug 5, 2020Aug 7, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
800$6.42$5.1K35,358Aug 5, 2020Aug 7, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
800——145,000Aug 5, 2020Aug 7, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
400$20.14$8.1K34,558Aug 4, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
400——145,800Aug 4, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
400$6.42$2.6K34,958Aug 4, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
2,000$8.26$16.5K36,558Aug 3, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
2,000——18,000Aug 3, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
5,800$20.01$116.1K34,558Aug 3, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
3,800——146,200Aug 3, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
3,800$6.42$24.4K40,358Aug 3, 2020Aug 5, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
50,000——116,667Mar 31, 2020Apr 10, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
5,354——34,558Mar 31, 2020Apr 10, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
President and CSO
16,666——39,912Mar 31, 2020Apr 10, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
SALE
President and CSO
16,666——100,001Mar 31, 2020Apr 10, 2020 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Feb 5, 2020Feb 12, 2020 ↗View →
Other insiders · CUE
Loading peer insiders…
About this filer
CIK 0001739130
ROLE
President and CSO
PRIMARY
CUE
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001739130DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback